Nested multiplex PCR based detection of human papillomavirus in cervical carcinoma patients of North-East India

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 2, 2013, Pages 785-790

  Das, Debabrata ^a   Rai, Avdhesh Kumar ^a   Kataki, Amal Chandra ^a   Barmon, Debabrata ^a   Deka, Pankaj ^a   Sharma, Jagannath Dev ^a   Sarma, Anupam ^a   Shrivastava, Sushruta ^a   Bhattacharyya, Mouchumee ^a   Kalita, Apurba Kumar ^a   Sharma, Mousumi ^a   Ahmed, Shiraj ^a  

^a A Unit of Tata Memorial Centre   (India)

Author keywords

Cervical cancer; HPV; Nested multiplex PCR; North East India

Indexed keywords

VIRUS DNA;

ARTICLE; FEMALE; GENETICS; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; INDIA; ISOLATION AND PURIFICATION; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; UTERINE CERVIX TUMOR; VIROLOGY;

DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 31; HUMANS; INDIA; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; UTERINE CERVICAL NEOPLASMS;

EID: 84877673692     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.2.785     Document Type: Article

References (25)

1. Basu P, Roychowdhury S, Bafna UD, et al(2009). Human papillomavirus genotype distribution in cervical cancer in india: results from a multi-center study. Asian Pac J Cancer Prev, 10, 27-34
2. Bhatla N, Lal N, Bao YP, Ng T, Qiao YL (2008). A meta-analysis of human papillomavirus type-distribution in women from South Asia: Implications for vaccination. Vaccine, 26, 2811-7.
3. Bosch FX, Manos MM, Munoz N, et al(1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J National Cancer Institute, 87, 796-802.
4. Bouvard V, Baan R, Straif K, et al(2009). A review of human carcinogens-part B: biological agents. Lancet Oncol, 10, 321-2.
5. Broomall EM, Reynolds SM, Jacobson RM (2010). Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus. Postgraduate Med, 122, 121-9.
6. Burchell AN, Winer RL, Sanjośe SD, Franco EL (2006). Epidemiology and transmission dynamics of genital HPV infection. Vaccine, 24, 52-61
7. Castellsagué X (2008). Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol, 110, 4-7.
8. Cuschieri KS, Cubie HA, Whitley MW, et al(2004). Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clinical Pathol, 57, 68-72.
9. Das BC, Gopalkrishna V, Das DK, et al(1993). Human papillomavirus DNA sequences in adenocarcinoma of the uterine cervix in Indian women. Cancer, 72, 147-53.
10. Deodhar K, Gheit T, Vaccarella S, et al(2012). Prevalence of human papillomavirus types in cervical lesions from women in rural Western India. J Med Virology, 84, 1054-60.
11. Ferlay J, Shin HR, Bray F, et al(2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
12. Franceschi S, Plummer M, Clifford G, et al(2009). Differences in the risk of cervical cancer and human papillomavirus infection by education level. Br J Cancer, 101, 865-70.
13. Gabriella MA, Anna RG (2011). Genital HPV infection and related lesions in men. Prev Med, 53, 36-41.
14. Ghosh SK, Choudhury B, Hansa J, et al(2011). Human papillomavirus testing for suspected cervical cancer patients from southern assam by fast-PCR. Asia Pac J Cancer Prev, 12, 749-51.
15. Gopalkrishna V, Hedau S, Kailash U, Das BC (2000). Human papillomavirus type 16 in cancer of the uterine cervix in different geographical regions of India. International HPV conference 2000. Abstract, 077.
16. Herrero R, Castle PE, Schiffman M, et al(2005). Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infectious Disease, 191, 1796-807.
17. Iwasawa A, Nieminen P, Lehtinen M, Paavonen J (1996). Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer, 77, 2275-79.
18. Munoz N, Castellsagué X, de Gonzalez AB, Gissmann L(2006). HPV in the etiology of human cancer. Vaccine, 24, 1-10.
19. Pista A, Oliveira A, Verdasca N, Ribeiro F (2010). Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women. Clin Microbiol Infection, 17, 941-6.
20. Raychaudhuri S, Mandal S (2012). Current status of knowledge, attitude and practice (KAP) and screening for cervical cancer in countries at different levels of development. Asian Pac J Cancer Prev, 13, 4221-7.
21. Sankaranarayanan R, Chatterji R, Shastri SS, et al (2004). Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer, 112, 341-7
22. Schiffman M, Wentzensen N, Wacholder S, et al (2011). Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst, 103, 368-83.
23. Smith JS, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 121, 621-32.
24. Sotlar K, Diemer D, Dethleffs A, et al (2004). Detection and typing of human papillomavirus by E6 nested multiplex PCR. J Clinical Microbiol, 42, 3176-84.
25. Thulaseedharan JV, Malila N, Hakama M, et al(2012). Socio- demographic and reproductive risk factors for cervical cancer - a large prospective cohort study from rural India. Asia Pac J Cancer Prev, 13, 2991-5.